The dollar was poised for a third weekly gain on Friday after positive U.S. economic data lowered expectations for rate cuts ...
Henry Schein (HSIC) stock is in focus after the company secured exclusive U.S. distribution rights for CytoChip’s FDA-cleared CitoCBC system, the first cartridge-based CBC device with a CLIA Waiver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback